- From confidence to capital: Positioning biotech for the next growth cycle<p>How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.</p>BioPharma Dive · 1h ago↗ source
- Anthropic’s life science plans; Novartis CEO on China deals; and moreWelcome back to Endpoints Weekly! We’re gearing up for a busy week of earnings coverage, as Moderna, AstraZeneca, GSK, Bristol Myers Squibb and more are set to report their Q2 results. In the meant…Endpoints · 2d ago↗ source
- Amgen shares new Tavneos analysis in effort to resolve FDA disputeAmgen shared a new analysis with the FDA that the company said supports keeping its controversial rare disease drug Tavneos on the market. The submission, made Thursday, includes an independent r…